Sep 25, 2025 7:00am EDT Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
Sep 19, 2025 4:39pm EDT Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
Jun 30, 2025 5:29pm EDT Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
May 13, 2025 7:00am EDT Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology
Apr 08, 2025 7:00am EDT Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease
